BIO applauded introduction of Vaccine Access, Certainty, and Innovation Act of 2015 by noting how it would stimulate new vaccine research and improve patient access. In his statement, BIO President and CEO Jim Greenwood thanked Representatives Ellmers and Butterfield "for their leadership in authoring and sponsoring this important legislation." Greenwood also expressed enthusiastic anticipation regarding further work on said bill and other components of 21st Century Cures Initiative.